Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Isolator Technology: Industry Wants Revised Regulations To Encourage Use

Executive Summary

FDA should encourage the use of isolator technology by ensuring an open regulatory environment, committee guests agreed at the Pharmaceutical Science Advisory Committee meeting on Oct. 22

You may also be interested in...



FDA Manufacturing Subcmte. Should Track Industry/Agency Disputes – PhRMA

FDA's Pharmaceutical Science Advisory Committee's Manufacturing Subcommittee should track disputes between industry and the agency to identify areas in need of standards development, the Pharmaceutical Researchers & Manufacturers of America said

FDA Manufacturing Subcmte. Should Track Industry/Agency Disputes – PhRMA

FDA's Pharmaceutical Science Advisory Committee's Manufacturing Subcommittee should track disputes between industry and the agency to identify areas in need of standards development, the Pharmaceutical Researchers & Manufacturers of America said

Aseptic processing concept paper

FDA expects to release a "concept paper" on aseptic processing in time for the Pharmaceutical Science Advisory Committee to review it at a meeting tentatively scheduled for Oct. 21-22. Industry has called upon FDA to revise its guidance on aseptic processing (1"The Pink Sheet" April 22, p. 18). FDA's aseptic processing guidance was issued in 1987; the agency is preparing an updated draft guidance it hopes to publish by the end of the year...

Related Content

UsernamePublicRestriction

Register

PS040731

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel